Bladder cancer diagnosis is a challenging task because of its intricacy and variation of tumor features. Moreover, morphological similarities of the cancerous cells make manual diagnosis time-consuming. Recently, machine learning and deep learning me...
Bladder cancer (BC) remains a significant global health concern, with substantial sex and racial disparities in incidence, progression, and outcomes. BC is the sixth most common cancer among males and the seventeenth most common among females worldwi...
BACKGROUND/AIM: Bladder cancer (BCa) is associated with high recurrence rates, emphasizing the importance of early and accurate detection. This study aimed to develop a lightweight and fast deep learning model, Light-Bladder-Net (LBN), for non-invasi...
Journal of the American Medical Informatics Association : JAMIA
Apr 1, 2025
OBJECTIVES: Explanations help to understand why anomaly detection algorithms identify data as anomalous. This study evaluates whether robustly standardized explanation scores correctly identify the implausible variables that make cancer data anomalou...
Journal of cellular and molecular medicine
Feb 1, 2025
The aim of this study was to validate the diagnostic potential of four previously identified miRNAs in two independent cohorts and to develop accurate classification models to predict invasiveness of bladder cancer. Furthermore, molecular subtypes we...
BACKGROUND: cfDNA fragmentomics-based liquid biopsy is a potential option for noninvasive bladder cancer (BLCA) detection that remains an unmet clinical need.
Studies in health technology and informatics
Aug 22, 2024
BACKGROUND: Urothelial Bladder Cancer (UBC) is a common cancer with a high risk of recurrence, which is influenced by the TNM classification, grading, age, and other factors. Recent studies demonstrate reliable and accurate recurrence prediction usin...
The ongoing growth of artificial intelligence (AI) involves virtually every aspect of oncologic care in medicine. Although AI is in its infancy, it has shown great promise in the diagnosis of oncologic urological conditions. This paper aims to explor...
This study aims to explore the possibility and bottleneck of clinical translation for an artificial intelligence (AI) diagnosis system for bladder cancer based on cystoscopy.We retrospectively collected videos of 101 bladder cancer patients from Janu...
BACKGROUND: Avelumab first-line (1 L) maintenance is a standard of care for advanced urothelial carcinoma (aUC) based on the JAVELIN Bladder 100 phase 3 trial, which showed that avelumab 1 L maintenance + best supportive care (BSC) significantly prol...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.